Abbott gets FDA nod for advanced femtosecond laser for cataract surgery
Bayer
Report: Medtronic to shutter Ventor’s Israeli shop | Wall Street Beat
Medtronic (NYSE:MDT) is shutting down heart valve maker Ventor Technologies, which it acquired in 2009, and moving its R&D efforts to other site, according to an Israeli business journal.
Netanya, Israel-based Ventor is developing an aortic replacement valve called the Engager. Medtronic bought the company for $325 million 3 years ago.
Simbionix buys GMV’s Arthro VR training simulator | Deals Roundup
Simbionix USA Corp. acquired the Arthro VR arthroscopic training simulator line from Spain’s GMV for an undisclosed amount.
The deal broadens Simbionix’s footprint in the orthopedic training arena. The Arthro VR features a line of simulated procedures using fiberglass limb replicas, 3D images and haptic sensation.
Wall Street reacts to Abbott’s spinout plan
Abbott’s (NYSE:ABT) plan to spinout its pharmaceuticals division met with a lukewarm response from investors and mixed views on whether other pharma firms will bid for the new firm.
The health care giant dropped the bombshell news along with its third-quarter results earlier this week, saying it planned to keep its medical products business under the Abbott banner and create a new, as-yet-unnamed public company from the pharma unit.
Toshiba increases MR efficiency with M-Power | Regulatory Roundup
Toshiba Medical’s M-Power interface, a customizable MRI system designed to accelerate the scanning process and enhance diagnoses. M-Power will be availble for use on Toshiba’s Vantage Atlas, Vantage Titan, and Titan3T system.
The interface uses a drag and drop method that, Toshiba said, will enhance useability, allowing technicians to favorite the most frequently used scanning tools.
Sign up to get our free newsletters delivered right to your inbox.
Medrad receives CE Mark for Cotavance
Launch of next generation of Cotavance paclitaxel coated balloon angioplasty catheter with Paccocath® technology / New Cotavance catheter platform includes improved paclitaxel coating process and dose control
Bayer Healthcare’s MedRad unit buys Pathway Medical | Mergers & Acquisitions Roundup
Bayer HealthCare’s (ETR:BAYN) MedRad subsidiary paid an undisclosed amount for Pathway Medical Technologies Inc. and its atherectomy technology.
Kirkland, Wash.-based Pathway makes mechanical devices used to the clear blood vessel blockages in the leg known as peripheral arterial disease. The devices cut away the arterial plaque that constricts blood flow in the leg.
Aptiv widens footprint in med-tech regulation with MDCI buyout | Acquisitions roundup
Life sciences consulting company Aptiv Solutions announced that it acquired Medical Device Consultants Inc., broadening its reach in medical device regulation and strategy.
North Attleboro, Mass.-based regulatory consulting and clinical research organization MDCI has been around since 1980, offering regulatory and clinical services to the med-tech sector.
Medtronic’s former CEO Bill Hawkins talks shop, Bayer’s international recall, Abiomed gets some Wall Street love | MassDevice.com +3
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
UPDATED: Diabetes – Bayer recall of diabetes test strips comes to the U.S., Bayer provides comment
Updated: 8/17/2011 11:30 p.m.
Bayer HealthCare confirmed that it has recalled all retail stock of its Contour 10- and 25-count and Counter TS 10-count diabetes test strips over a "packaging issue" that resulted in inaccurate glucose readings in some of its products.
Bayer’s voluntary recall in the U.S. joins government-recall of all Contour glucose testing strips in Hong Kong. *
Diabetes: Bayer recall of diabetes test strips comes to the U.S.
Bayer HealthCare confirmed that it has recalled all retail stock of its Contour 10 and 25 count diabetes test strips over a "packaging issue" that resulted in inaccurate glucose readings in some of its products.
Bayer’s voluntary recall in the U.S. appears to follow a government-recall of all Contour glucose testing strips in Hong Kong.